Perhaps you think it's impossible to score another 1,000% gain off this "tech titan" stock. Think again. An unusual strategy lets you virtually "recreate" gains off the biggest companies you thought had come and gone. CLICK HERE to see how it works.
by The Investment U Research Team
American International Group (NYSE: AIG) has been taking a beating over the past two weeks, and even with its recent 20-1 reverse stock split, it’s been headed back down.
So far in fact, that we’re getting close to the price we talked about on March 9 – $.35 (or split adjusted $7.00).
At that time, we recommended readers go the route of John Templeton and pick up some penny stocks in the S&P 500. Moreover, just ten days later readers who jumped in were rewarded with a 437% gain.
We could be setting up for a similar situation.
The stock split does change the dynamics – mostly emotional – of the current stock plunge. Investors feel better about selling at $9.00 than they did at .40, even though the value might be the same.
On the other hand, we could see this stock slip much lower that it did in March simply because the dynamics of short sellers and a higher price come into play.
While the news today has been centered upon the government approving bonuses for AIG employees, it’s not terribly important. Most of the big news concerning AIG, and the main reason it has fallen so much, is because Citigroup (NYSE: C) reported that AIG might have no shareholder equity.
Ouch. But how does that change things?
Regardless of whether this stock sinks lower – or much lower – as an investor/speculator considering the long-term movement of this stock you need to ask yourself two things.
One, are the long-term prospects of this stock any different than they were in March? Two, do you think the stock will go bankrupt? If you can easily answer these questions, than you have a good idea of why AIG could be another great short-term investment.
We’ll be keeping our eye on this one. Today the price is down to $8.5 – and as the stock price moves closer to $7, the more interested we’ll be.
Symbols mentioned in this article: AIG and C.
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed